Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Autoimmune Disorders

  Free Subscription


Articles published in Am J Kidney Dis

Retrieve available abstracts of 30 articles:
HTML format



Single Articles


    June 2025
  1. CHUNG EY, Carter SA, Jaure A, Howell M, et al
    Patients' Perspectives on Living With Primary Membranous Nephropathy: A Semi-Structured Interview Study.
    Am J Kidney Dis. 2025 Jun 17:S0272-6386(25)00908.
    PubMed     Abstract available


    May 2025

  2. Erratum regarding "Lupus Nephritis Patterns and Response to Type I Interferon in Patients With DNASE1L3 Variants: Report of Three Cases" (Am J Kidney Dis. 2024;84(6):791-797).
    Am J Kidney Dis. 2025;85:666.
    PubMed    


    March 2025
  3. MORELLE J, Aydin S, Debiec H, Demoulin N, et al
    Mass Spectrometry With Data-Independent Acquisition for the Identification of Target Antigens in Membranous Nephropathy.
    Am J Kidney Dis. 2025 Mar 7:S0272-6386(25)00717.
    PubMed     Abstract available


  4. BU L, Valeri AM, Said SM, Zhu Y, et al
    IgM Variant of Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Series.
    Am J Kidney Dis. 2025 Mar 6:S0272-6386(25)00712.
    PubMed     Abstract available


    September 2024
  5. FRIMAT M, Maanaoui M, Schwotzer N, Lebas C, et al
    Non-Plasmapheresis Approaches for Managing Severe Renal Thrombotic Microangiopathy: A Report of 7 Cases.
    Am J Kidney Dis. 2024 Sep 27:S0272-6386(24)00978.
    PubMed     Abstract available


  6. FISCHMAN CJ, Holzman LB
    Identification of Nephrin Autoantibodies Signals New Chapter for Glomerular Disease.
    Am J Kidney Dis. 2024 Sep 18:S0272-6386(24)00972.
    PubMed    


  7. ZENI L, Mescia F, Toso D, Dordoni C, et al
    Clinical Significance of the Cystic Phenotype in Alport Syndrome.
    Am J Kidney Dis. 2024;84:320-328.
    PubMed     Abstract available


    August 2024
  8. DE COS M, Mosoyan G, Chauhan K, Troost JP, et al
    Urinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease.
    Am J Kidney Dis. 2024;84:205-214.
    PubMed     Abstract available


  9. VON SAMSON-HIMMELSTJERNA FA, Kakavand N, Voran JC, Kolbrink B, et al
    Use of Immunoadsorption and Plasma Exchange for Treating Anti-Glomerular Basement Membrane Disease: Clinical Experience in Germany.
    Am J Kidney Dis. 2024;84:255-258.
    PubMed    


    July 2024
  10. VOLPI S, Angelotti ML, Palazzini G, Antonelli G, et al
    Lupus Nephritis Patterns and Response to Type I Interferon in Patients With DNASE1L3 Mutations: Report of Three Cases.
    Am J Kidney Dis. 2024 Jul 24:S0272-6386(24)00892.
    PubMed     Abstract available


  11. IVKOVIC V, Kronbichler A, Caza TN
    "Atypical" Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All?
    Am J Kidney Dis. 2024;84:127-129.
    PubMed    


  12. CHAUVEAU B, Gibier JB, Rabant M
    In Reply to "'Atypical' Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All?".
    Am J Kidney Dis. 2024;84:129.
    PubMed    


    June 2024
  13. NAKAYAMA T, Kaneko H, Suzuki Y, Okada A, et al
    Chronic Tonsillitis and IgA Nephropathy: Findings From a Nationwide Japanese Cohort Study.
    Am J Kidney Dis. 2024 Jun 19:S0272-6386(24)00832.
    PubMed     Abstract available


  14. CORNELL LD
    Anti-Glomerular Basement Membrane Disease: Broadening the Spectrum.
    Am J Kidney Dis. 2024;83:701-703.
    PubMed    


  15. CHAUVEAU B, Gibier JB, Olagne J, Morel A, et al
    Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group.
    Am J Kidney Dis. 2024;83:713-728.
    PubMed     Abstract available


    May 2024
  16. SASAKI T, Tsuboi N
    Time-Varying Proteinuria in Predicting Outcome of IgA Nephropathy.
    Am J Kidney Dis. 2024 May 11:S0272-6386(24)00755.
    PubMed    


    March 2024
  17. HONDA D, Okunaga I, Omote D, Inoue H, et al
    Anti-Neuron-Derived Neurotrophic Factor Antibodies in Secondary Membranous Nephropathy Caused by Syphilis: A Case Report.
    Am J Kidney Dis. 2024 Mar 22:S0272-6386(24)00685.
    PubMed     Abstract available


    February 2024
  18. TANG C, Chen P, Si FL, Lv JC, et al
    Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study.
    Am J Kidney Dis. 2024 Feb 14:S0272-6386(24)00609.
    PubMed     Abstract available


    January 2024
  19. MIGNANO SE, Pascal V, Odioemene NE, Forehand W, et al
    Monoclonal Immunoglobulin Crystalline Membranous Nephropathy.
    Am J Kidney Dis. 2024 Jan 22:S0272-6386(24)00041.
    PubMed     Abstract available


  20. BECK LH JR
    Quantity Versus Quality of Anti-Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate Continues.
    Am J Kidney Dis. 2024 Jan 22:S0272-6386(23)00995.
    PubMed    


  21. PAUEKSAKON P, Najafian B, Alpers CE, Fogo AB, et al
    AJKD Atlas of Renal Pathology: IgA-Dominant Infection-Related Glomerulonephritis.
    Am J Kidney Dis. 2024;83:e1-e2.
    PubMed    


  22. WANG CS, Glenn DA, Helmuth M, Smith AR, et al
    Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study.
    Am J Kidney Dis. 2024;83:37-46.
    PubMed     Abstract available


    December 2023
  23. MASSICOTTE-AZARNIOUCH D, Detwiler RK, Hu Y, Falk RJ, et al
    Infections Following Kidney Transplantation After Exposure to Immunosuppression for Treatment of Glomerulonephritis.
    Am J Kidney Dis. 2023 Dec 29:S0272-6386(23)01000.
    PubMed     Abstract available


  24. RUGGENENTI P, Reinhard L, Ruggiero B, Perna A, et al
    Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.
    Am J Kidney Dis. 2023 Dec 25:S0272-6386(23)00993.
    PubMed     Abstract available


  25. CANNEY M, Gunning HM, Johnston JC, Induruwage D, et al
    Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort Study.
    Am J Kidney Dis. 2023;82:725-736.
    PubMed     Abstract available


    September 2023
  26. PODESTA MA, Trillini M, Portalupi V, Gennarini A, et al
    Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy.
    Am J Kidney Dis. 2023 Sep 28:S0272-6386(23)00838.
    PubMed     Abstract available


  27. CASTER DJ, Lafayette RA
    The Treatment of Primary IgA Nephropathy: Change, Change, Change.
    Am J Kidney Dis. 2023 Sep 22:S0272-6386(23)00831.
    PubMed     Abstract available


  28. AFOLABI H, Zhang BM, O'Shaughnessy M, Chertow GM, et al
    The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease.
    Am J Kidney Dis. 2023 Sep 18:S0272-6386(23)00797.
    PubMed     Abstract available


  29. KEARNEY AO, Lerma E, Lin J
    Building Towards Clinical Translation: New Study Refines Genetic Architecture of IgA Nephropathy.
    Am J Kidney Dis. 2023 Sep 14:S0272-6386(23)00794.
    PubMed    


  30. ELEY S, Morales-Alvarez MC, Vanguri VK, Chopra B, et al
    An Unusual Case of Anti-Glomerular Basement Membrane Disease and PLA2R-Associated Membranous Nephropathy After Exposure to Hydrocarbons.
    Am J Kidney Dis. 2023 Sep 13:S0272-6386(23)00793.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.